Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2

Epigenetics

Volumn 11, Issue 6, 2016, Pages 449-455

  Bhoi, Sujata ^a   Ljungström, Viktor ^a   Baliakas, Panagiotis ^a   Mattsson, Mattias ^a   Smedby, Karin E ^b   Juliusson, Gunnar ^c   Rosenquist, Richard ^a   Mansouri, Larry ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

CLL; epigenetic classification; methylation; prognosis

Indexed keywords

CD38 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLUSTER ANALYSIS; DNA METHYLATION; EPIGENETICS; FEMALE; FLOW CYTOMETRY; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PYROSEQUENCING; SEQUENCE ANALYSIS; SUPPORT VECTOR MACHINE; CLASSIFICATION; GENETIC EPIGENESIS; GENETICS; LEUKEMIA, PROLYMPHOCYTIC, B-CELL; MUTATION; PROGNOSIS; STANDARDS; SURVIVAL ANALYSIS; VALIDATION STUDY;

ADULT; AGED; BIOMARKERS, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; LEUKEMIA, PROLYMPHOCYTIC, B-CELL; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84973167177     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2016.1178432     Document Type: Article

References (30)

1. G.Strathdee, R.Brown. Aberrant DNA methylation in cancer: potential clinical interventions. Exp Rev Mol Med 2002; 4:1-17; PMID:14987388; http://dx.doi.org/10.1017/S1462399402004222
2. M.Corcoran, A.Parker, J.Orchard, Z.Davis, M.Wirtz, O.J.Schmitz, D.Oscier. ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia. Haematologica 2005; 90:1078-88; PMID:16079107
3. S.P.Chantepie, D.Vaur, C.Grunau, V.Salaun, M.Briand, J.J.Parienti, N.Heutte, S.Cheze, M.Roussel, P.Gauduchon, et al. ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia. Leukemia Res 2010; 34:800-8; PMID:19944462; http://dx.doi.org/10.1016/j.leukres.2009.10.018
4. R.Claus, D.M.Lucas, A.S.Ruppert, K.E.Williams, D.Weng, K.Patterson, M.Zucknick, C.C.Oakes, L.Z.Rassenti, A.W.Greaves, et al. Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia. Blood 2014; 124:42-8; PMID:24868078; http://dx.doi.org/10.1182/blood-2014-02-555722
5. R.Claus, D.M.Lucas, S.Stilgenbauer, A.S.Ruppert, L.Yu, M.Zucknick, D.Mertens, A.Buhler, C.C.Oakes, R.A.Larson, et al. Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. J Clin Oncol 2012; 30:2483-91; PMID:22564988; http://dx.doi.org/10.1200/JCO.2011.39.3090
6. C.Abreu, P.Moreno, F.Palacios, M.Borge, P.Morande, A.I.Landoni, R.Gabus, G.Dighiero, M.Giordano, R.Gamberale, et al. Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemia. Leukemia & lymphoma 2013; 54:1844-8; PMID:23614796; http://dx.doi.org/10.3109/10428194.2013.796057
7. P.Moreno, C.Abreu, M.Borge, F.Palacios, P.Morande, M.Pegazzano, S.Bianchi, A.I.Landoni, R.Agrelo, M.Giordano, et al. Lipoprotein lipase expression in unmutated CLL patients is the consequence of a demethylation process induced by the microenvironment. Leukemia 2013; 27:721-5; PMID:22828442; http://dx.doi.org/10.1038/leu.2012.212
8. G.Strathdee, T.L.Holyoake, A.Sim, A.Parker, D.G.Oscier, J.V.Melo, S.Meyer, T.Eden, A.M.Dickinson, J.C.Mountford, et al. Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res 2007; 13:5048-55; PMID:17785556; http://dx.doi.org/10.1158/1078-0432.CCR-07-0919
9. G.Strathdee, A.Sim, A.Parker, D.Oscier, R.Brown. Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL. Leukemia 2006; 20:1326-9; PMID:16688227; http://dx.doi.org/10.1038/sj.leu.2404254
10. T.Shinawi, V.Hill, A.Dagklis, P.Baliakas, K.Stamatopoulos, A.Agathanggelou, T.Stankovic, E.R.Maher, P.Ghia, F.Latif. KIBRA gene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia. Epigenetics 2012; 7:211-5; PMID:22430796; http://dx.doi.org/10.4161/epi.7.3.19222
11. V.K.Hill, T.L.Dunwell, D.Catchpoole, D.Krex, A.T.Brini, M.Griffiths, C.Craddock, E.R.Maher, F.Latif. Frequent epigenetic inactivation of KIBRA, an upstream member of the Salvador/Warts/Hippo (SWH) tumor suppressor network, is associated with specific genetic event in B-cell acute lymphocytic leukemia. Epigenetics 2011; 6:326-32; PMID:21173572; http://dx.doi.org/10.4161/epi.6.3.14404
12. A.Raval, D.M.Lucas, J.J.Matkovic, K.L.Bennett, S.Liyanarachchi, D.C.Young, L.Rassenti, T.J.Kipps, M.R.Grever, J.C.Byrd, et al. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. J Clin Oncol 2005; 23:3877-85; PMID:15809452; http://dx.doi.org/10.1200/JCO.2005.02.196
13. L.Irving, T.Mainou-Fowler, A.Parker, R.E.Ibbotson, D.G.Oscier, G.Strathdee. Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia. Epigenetics 2011; 6:300-6; PMID:21051931; http://dx.doi.org/10.4161/epi.6.3.14038
14. M.Kanduri, N.Cahill, H.Goransson, C.Enstrom, F.Ryan, A.Isaksson, R.Rosenquist. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood 2010; 115:296-305; PMID:19897574; http://dx.doi.org/10.1182/blood-2009-07-232868
15. M.Kulis, S.Heath, M.Bibikova, A.C.Queiros, A.Navarro, G.Clot, A.Martinez-Trillos, G.Castellano, I.Brun-Heath, M.Pinyol, et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet 2012; 44:1236-42; PMID:23064414; http://dx.doi.org/10.1038/ng.2443
16. N.Cahill, A.C.Bergh, M.Kanduri, H.Goransson-Kultima, L.Mansouri, A.Isaksson, F.Ryan, K.E.Smedby, G.Juliusson, C.Sundstrom, et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 2013; 27:150-8; PMID:22922567; http://dx.doi.org/10.1038/leu.2012.245
17. A.C.Queiros, N.Villamor, G.Clot, A.Martinez-Trillos, M.Kulis, A.Navarro, E.M.Penas, S.Jayne, A.Majid, J.Richter, et al. A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact. Leukemia 2015; 29:598-605; PMID:25151957; http://dx.doi.org/10.1038/leu.2014.252
18. G.Tobin, U.Thunberg, A.Johnson, I.Eriksson, O.Soderberg, K.Karlsson, M.Merup, G.Juliusson, J.Vilpo, G.Enblad, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003; 101:4952-7; PMID:12586612; http://dx.doi.org/10.1182/blood-2002-11-3485
19. M.Thorselius, A.Krober, F.Murray, U.Thunberg, G.Tobin, A.Buhler, D.Kienle, E.Albesiano, R.Maffei, L.P.Dao-Ung, et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood 2006; 107:2889-94; PMID:16317103; http://dx.doi.org/10.1182/blood-2005-06-2227
20. P.Baliakas, A.Agathangelidis, A.Hadzidimitriou, L.A.Sutton, E.Minga, A.Tsanousa, L.Scarfo, Z.Davis, X.J.Yan, T.Shanafelt, et al. Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations. Blood 2015; 125:856-9; PMID:25634617; http://dx.doi.org/10.1182/blood-2014-09-600874
21. X.S.Puente, S.Bea, R.Valdes-Mas, N.Villamor, J.Gutierrez-Abril, J.I.Martin-Subero, M.Munar, C.Rubio-Perez, P.Jares, M.Aymerich, et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 2015; 526:519-24; PMID:26200345; http://dx.doi.org/10.1038/nature14666
22. J.C.Strefford, L.A.Sutton, P.Baliakas, A.Agathangelidis, J.Malcikova, K.Plevova, L.Scarfo, Z.Davis, E.Stalika, D.Cortese, et al. Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia 2013; 27:2196-9; PMID:23558524; http://dx.doi.org/10.1038/leu.2013.98
23. K.E.Smedby, H.Hjalgrim, M.Melbye, A.Torrang, K.Rostgaard, L.Munksgaard, J.Adami, M.Hansen, A.Porwit-MacDonald, B.A.Jensen, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005; 97:199-209; PMID:15687363; http://dx.doi.org/10.1093/jnci/dji022
24. M.Hallek, B.D.Cheson, D.Catovsky, F.Caligaris-Cappio, G.Dighiero, H.Dohner, P.Hillmen, M.J.Keating, E.Montserrat, K.R.Rai, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111:5446-56; PMID:18216293; http://dx.doi.org/10.1182/blood-2007-06-093906
25. A.Agathangelidis, N.Darzentas, A.Hadzidimitriou, X.Brochet, F.Murray, X.J.Yan, Z.Davis, E.J.van Gastel-Mol, C.Tresoldi, C.C.Chu, et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood 2012; 119:4467-75; PMID:22415752; http://dx.doi.org/10.1182/blood-2011-11-393694
26. F.Murray, N.Darzentas, A.Hadzidimitriou, G.Tobin, M.Boudjogra, C.Scielzo, N.Laoutaris, K.Karlsson, F.Baran-Marzsak, A.Tsaftaris, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008; 111:1524-33; PMID:17959859; http://dx.doi.org/10.1182/blood-2007-07-099564
27. U.Thunberg, A.Johnson, G.Roos, I.Thorn, G.Tobin, J.Sallstrom, C.Sundstrom, R.Rosenquist. CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. Blood 2001; 97:1892-4; PMID:11263438; http://dx.doi.org/10.1182/blood.V97.6.1892
28. R.Gunnarsson, J.Staaf, M.Jansson, A.M.Ottesen, H.Goransson, U.Liljedahl, U.Ralfkiaer, M.Mansouri, A.M.Buhl, K.E.Smedby, et al. Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia–a comparative study of four differently designed, high resolution microarray platforms. Genes Chromosomes Cancer 2008; 47:697-711; PMID:18484635; http://dx.doi.org/10.1002/gcc.20575
29. D.Cortese, L.A.Sutton, N.Cahill, K.E.Smedby, C.Geisler, R.Gunnarsson, G.Juliusson, L.Mansouri, R.Rosenquist. On the way towards a ‘CLL prognostic index’: focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort. Leukemia 2014; 28:710-3; PMID:24217197; http://dx.doi.org/10.1038/leu.2013.333
30. A.Sturn, J.Quackenbush, Z.Trajanoski. Genesis: cluster analysis of microarray data. Bioinformatics 2002; 18:207-8; PMID:11836235; http://dx.doi.org/10.1093/bioinformatics/18.1.207